Komiya S - Search Results

1

An optimal promoter regulating cytokine transgene expression is crucial for safe and effective oncolytic virus immunotherapy.

Kawakami H, Ijichi N, Obama Y, Matsuda E, Mitsui K, Nishikawaji Y, Watanabe M, Nagano S, Taniguchi N, Komiya S, Kosai KI. Kawakami H, et al. Among authors: komiya s. Transl Res. 2024 Nov;273:32-45. doi: 10.1016/j.trsl.2024.07.002. Epub 2024 Jul 3. Transl Res. 2024. PMID: 38969167 Free article.

2

Survivin-responsive conditionally replicating adenovirus kills rhabdomyosarcoma stem cells more efficiently than their progeny.

Tanoue K, Wang Y, Ikeda M, Mitsui K, Irie R, Setoguchi T, Komiya S, Natsugoe S, Kosai K. Tanoue K, et al. Among authors: komiya s. J Transl Med. 2014 Jan 27;12:27. doi: 10.1186/1479-5876-12-27. J Transl Med. 2014. PMID: 24467821 Free PMC article.

3

An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in mice.

Terazaki Y, Yano S, Yuge K, Nagano S, Fukunaga M, Guo ZS, Komiya S, Shirouzu K, Kosai K. Terazaki Y, et al. Among authors: komiya s. Hepatology. 2003 Jan;37(1):155-63. doi: 10.1053/jhep.2003.50018. Hepatology. 2003. PMID: 12500200

4

Gene therapy eradicating distant disseminated micro-metastases by optimal cytokine expression in the primary lesion only: novel concepts for successful cytokine gene therapy.

Nagano S, Yuge K, Fukunaga M, Terazaki Y, Fujiwara H, Komiya S, Kosai K. Nagano S, et al. Among authors: komiya s. Int J Oncol. 2004 Mar;24(3):549-58. Int J Oncol. 2004. PMID: 14767539

5

Survivin-responsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication.

Kamizono J, Nagano S, Murofushi Y, Komiya S, Fujiwara H, Matsuishi T, Kosai K. Kamizono J, et al. Among authors: komiya s. Cancer Res. 2005 Jun 15;65(12):5284-91. doi: 10.1158/0008-5472.CAN-04-2657. Cancer Res. 2005. PMID: 15958575

6

Validation of Different Nutritional Assessment Tools in Predicting Prognosis of Patients with Soft Tissue Spindle-Cell Sarcomas.

Sasaki H, Nagano S, Komiya S, Taniguchi N, Setoguchi T. Sasaki H, et al. Among authors: komiya s. Nutrients. 2018 Jun 13;10(6):765. doi: 10.3390/nu10060765. Nutrients. 2018. PMID: 29899304 Free PMC article.

7

Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: a promising implication of telomerase-dependent targeted cancer gene therapy.

Murofushi Y, Nagano S, Kamizono J, Takahashi T, Fujiwara H, Komiya S, Matsuishi T, Kosai K. Murofushi Y, et al. Among authors: komiya s. Int J Oncol. 2006 Sep;29(3):681-8. Int J Oncol. 2006. PMID: 16865285

8

Tranilast enhances the effect of anticancer agents in osteosarcoma.

Nakashima T, Nagano S, Setoguchi T, Sasaki H, Saitoh Y, Maeda S, Komiya S, Taniguchi N. Nakashima T, et al. Among authors: komiya s. Oncol Rep. 2019 Jul;42(1):176-188. doi: 10.3892/or.2019.7150. Epub 2019 May 6. Oncol Rep. 2019. PMID: 31059083 Free PMC article.

9

Current therapeutic modalities and newly designed gene therapy for refractory sarcomas.

Komiya S, Nagano S, Setoguchi T. Komiya S, et al. J Orthop Sci. 2019 Sep;24(5):764-769. doi: 10.1016/j.jos.2018.10.027. Epub 2019 Jun 11. J Orthop Sci. 2019. PMID: 31196729 Free article. Review. No abstract available.

10

TGF-β Promotes the Proliferation of Microglia In Vitro.

Bureta C, Setoguchi T, Saitoh Y, Tominaga H, Maeda S, Nagano S, Komiya S, Yamamoto T, Taniguchi N. Bureta C, et al. Among authors: komiya s. Brain Sci. 2019 Dec 30;10(1):20. doi: 10.3390/brainsci10010020. Brain Sci. 2019. PMID: 31905898 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters